Investigation of epstein-barr virus and parvovirus b19 DNA in allogeneic stem cell transplant patients

about

Parvovirus B19 in the Context of Hematopoietic Stem Cell Transplantation: Evaluating Cell Donors and Recipients.

P2860

Q47147160-751BA500-725F-47D8-B30B-ECD9818066C3

P2860

Investigation of epstein-barr virus and parvovirus b19 DNA in allogeneic stem cell transplant patients

Item

http://www.wikidata.org/entity/Q41993877

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Investigation of epstein-barr ...... stem cell transplant patients

@en

type

Item

label

Investigation of epstein-barr ...... stem cell transplant patients

@en

prefLabel

Investigation of epstein-barr ...... stem cell transplant patients

@en

P1476

Investigation of epstein-barr ...... stem cell transplant patients

@en

P2093

Altay Atalay

http://www.w3.org/2001/XMLSchema#string

Bülent Eser

http://www.w3.org/2001/XMLSchema#string

Derya Sağlam

http://www.w3.org/2001/XMLSchema#string

Hüseyin Kılıç

http://www.w3.org/2001/XMLSchema#string

Idris Kandemir

http://www.w3.org/2001/XMLSchema#string

Selma Gökahmetoğlu

http://www.w3.org/2001/XMLSchema#string

Süleyman Durmaz

http://www.w3.org/2001/XMLSchema#string

P2860

Parvovirus B19 infection in pediatric solid-organ and bone marrow transplantation.

New LightCycler PCR for rapid and sensitive quantification of parvovirus B19 DNA guides therapeutic decision-making in relapsing infections

Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease.

Increased risk of parvovirus B19 infection in young adult cancer patients receiving multiple courses of chemotherapy.

Diagnosis and treatment of posttransplantation lymphoproliferative disease after hematopoietic stem cell transplantation.

B19 virus infection in renal transplant recipients.

Virological aspects of Epstein-Barr virus infections.

Risk assessment in haematopoietic stem cell transplantation: viral status.

Emerging viruses in transplantation: there is more to infection after transplant than CMV and EBV.

Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases.

P304

155-160

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4274/TJH.2012.0042

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Leylagul Kaynar

M Cetin

P577

2014-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264053041

http://www.w3.org/2001/XMLSchema#string

P698

25035673

http://www.w3.org/2001/XMLSchema#string

P932

4102043

http://www.w3.org/2001/XMLSchema#string

Investigation of epstein-barr virus and parvovirus b19 DNA in allogeneic stem cell transplant patients

about

P2860

P2860

Investigation of epstein-barr virus and parvovirus b19 DNA in allogeneic stem cell transplant patients

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932